Europlasma SA offers hazardous and non-hazardous waste management solutions. The company specializes in waste vitrification and develops equipment used in plasma-arc treatment which produces glass-like, leach-resistant slag.
1992
116
LTM Revenue n/a
LTM EBITDA n/a
$17.6M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Europlasma has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Europlasma achieved revenue of $16.5M and an EBITDA of -$4.1M.
Europlasma expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Europlasma valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $15.6M | $16.5M | XXX | XXX | XXX |
Gross Profit | $5.4M | $6.1M | XXX | XXX | XXX |
Gross Margin | 35% | 37% | XXX | XXX | XXX |
EBITDA | -$4.4M | -$4.1M | XXX | XXX | XXX |
EBITDA Margin | -28% | -25% | XXX | XXX | XXX |
Net Profit | -$13.6M | -$17.1M | XXX | XXX | XXX |
Net Margin | -87% | -103% | XXX | XXX | XXX |
Net Debt | $0.8M | $4.7M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 18, 2025, Europlasma's stock price is EUR 0 (or $0).
Europlasma has current market cap of EUR 10.3M (or $11.0M), and EV of EUR 16.4M (or $17.6M).
See Europlasma trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$17.6M | $11.0M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 18, 2025, Europlasma has market cap of $11.0M and EV of $17.6M.
Europlasma's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Europlasma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Europlasma and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $17.6M | XXX | XXX | XXX |
EV/Revenue | 1.1x | XXX | XXX | XXX |
EV/EBITDA | -4.3x | XXX | XXX | XXX |
P/E | -0.7x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -1.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpEuroplasma's NTM/LTM revenue growth is n/a
Europlasma's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Europlasma's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Europlasma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Europlasma and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 6% | XXX | XXX | XXX | XXX |
EBITDA Margin | -25% | XXX | XXX | XXX | XXX |
EBITDA Growth | -6% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 154% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Arcadis | XXX | XXX | XXX | XXX | XXX | XXX |
Envipco | XXX | XXX | XXX | XXX | XXX | XXX |
Cleanaway | XXX | XXX | XXX | XXX | XXX | XXX |
The Environmental Group | XXX | XXX | XXX | XXX | XXX | XXX |
EnviroSuite | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Europlasma acquired XXX companies to date.
Last acquisition by Europlasma was XXXXXXXX, XXXXX XXXXX XXXXXX . Europlasma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Europlasma founded? | Europlasma was founded in 1992. |
Where is Europlasma headquartered? | Europlasma is headquartered in France. |
How many employees does Europlasma have? | As of today, Europlasma has 116 employees. |
Is Europlasma publicy listed? | Yes, Europlasma is a public company listed on PAR. |
What is the stock symbol of Europlasma? | Europlasma trades under ALEUP ticker. |
When did Europlasma go public? | Europlasma went public in 2009. |
Who are competitors of Europlasma? | Similar companies to Europlasma include e.g. Arcadis, Envipco, Cleanaway, The Environmental Group. |
What is the current market cap of Europlasma? | Europlasma's current market cap is $11.0M |
What is the current revenue growth of Europlasma? | Europlasma revenue growth between 2023 and 2024 was 6%. |
Is Europlasma profitable? | Yes, Europlasma is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.